http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6612724

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 294
issn 0920-1211
issueIdentifier 3
pageRange 286-294
publicationName Epilepsy Research
startingPage 286
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4f04ce88ae39f157e58131f17d961fe6
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2820c36905778e8beb7b26960110cf4c
bibliographicCitation Hartman AL. Neuroprotection in metabolism-based therapy. Epilepsy Research. 2012 Jul;100(3):286–94. doi: 10.1016/j.eplepsyres.2011.04.016.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f01b99cfcd2c0e26dde289e5133bb58b
date 201207
identifier https://doi.org/10.1016/j.eplepsyres.2011.04.016
https://pubmed.ncbi.nlm.nih.gov/21872441
https://pubmed.ncbi.nlm.nih.gov/PMC3245363
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
https://portal.issn.org/resource/ISSN/0920-1211
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Neuroprotection in metabolism-based therapy
discusses http://id.nlm.nih.gov/mesh/M0028008
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D019636Q000178
http://id.nlm.nih.gov/mesh/D010300Q000178
http://id.nlm.nih.gov/mesh/D055423
http://id.nlm.nih.gov/mesh/D031204
http://id.nlm.nih.gov/mesh/D000544Q000178
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D018696Q000627
http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10721
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9643
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6865
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8805
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10395
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191

Total number of triples: 39.